Low Grade Chondrosarcoma Versus Enchondroma

Chondrosarcoma Clinical Trial

— CONDRO1  

Official title:

Low Grade Chondrosarcoma Versus Enchondroma: Challenges in Diagnosis and Management

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02996747
• Other study ID #: 0016890
• Status: Completed
• Phase: N/A
• First received: December 15, 2016
• Last updated: December 21, 2016
• Start date: August 2016
• Est. completion date: December 2016

Study information

• Verified date: December 2016
• Source: Istituto Ortopedico Rizzoli
• Contact: n/a
• Is FDA regulated: No
• Health authority: Italy: Ethics Committee
• Study type: Observational

Clinical Trial Summary

The purpose of this project is to verify possible clinical and radiological findings with regard to distinguishing enchondroma from low grade chondrosarcoma of the long bones. In addition, this study presents the outcome of patients with enchondroma and low grade chondrosarcoma of the long bones who were treated with curettage (intralesional surgery).

Description:

The investigators retrospectively review the records of 65 patients with enchondroma and 37 patients with low grade chondrosarcoma of the limbs treated by curettage between 1988 and 2014 in a single Institution.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 102
• Est. completion date: December 2016
• Est. primary completion date: December 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• chondroma or low grade chondrosarcoma of long bones

Exclusion Criteria:

• chondroma or low grade chondrosarcoma of spine and pelvis

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Chondroma
• Chondrosarcoma

Intervention

Procedure:
• curettage (intralesional surgery)
comparison of two different tumors treated by curettage

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Istituto Ortopedico Rizzoli

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Local recurrence rate of patients with chondroma or low grade chondrosarcoma treated by curettage (intralesional surgery)		36 months	Yes